From: Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Characteristies | n | ETV5 expression | χ2 | P | |
---|---|---|---|---|---|
 | 87 | Over expression (%) | Low expression (%) |  |  |
Age | |||||
 < 55 | 44 | 20(45.5) | 24(54.5) | 4.587 | 0.032** |
 ≥55 | 43 | 32(74.4) | 11(25.6) |  |  |
FIGO stage | |||||
 I-II | 21 | 12(57.1) | 9(42.9) | 4.212 | 0.040* |
 III-IV | 66 | 40(60.6) | 26(39.4) |  |  |
Chemotherapy response | |||||
 sensitive | 26 | 10(38.5) | 16(61.5) | 6.502 | 0.011* |
 partial | 24 | 16(66.7) | 8(33.3) |  |  |
 unknown | 37 |  |  |  |  |
Recurrence | |||||
 No | 27 | 14(51.9) | 13(48.1) | 0.979 | 0.322 |
 Yes | 10 | 7(70.0) | 3(30.0) |  |  |
 unknown | 50 |  |  |  |  |
Ascites | |||||
 No | 26 | 15(57.7) | 11(42.3) | 0.201 | 0.654 |
 Yes | 61 | 32(52.5) | 29(47.5) |  |  |